Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05759013

Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree) for Weaning From Mechanical Ventilation

A Randomized, Sham Controlled, Double-blinded, Multi-center Trial to Evaluate the Efficacy of the VentFree Respiratory Muscle Stimulator to Assist Ventilator Weaning in Critically Ill Patients

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
272 (estimated)
Sponsor
Liberate Medical · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the efficacy of the VentFree Respiratory Muscle Stimulator (VentFree) in critically ill adult patients who require invasive mechanical ventilation, when compared to sham.

Detailed description

Approximately 40% of patients who receive invasive ventilation require more than four days of ventilator support. Every additional day of mechanical ventilation results in increased patient morbidity and mortality and increased economic cost. Mechanically ventilated patients often develop expiratory muscle weakness, which has been linked to failed extubation and weaning. Neuromuscular electrical stimulation (NMES) uses electrical pulses to induce a muscle contraction and has been shown to reduce or retard muscle atrophy. NMES applied to the abdominal wall muscles has been shown to improve respiratory function and assist ventilator weaning in spinal cord injury. Liberate Medical has previously shown that NMES applied to the abdominal wall muscles in synchrony with exhalation is feasible in patients receiving invasive mechanical ventilation. This study is a pivotal evaluation of the efficacy of exhalation synchronized abdominal NMES to assist ventilator weaning in critically ill patients.

Conditions

Interventions

TypeNameDescription
DEVICEBreath synchronized abdominal FESActive abdominal stimulation will be applied for 30 minutes twice per day (minimum of four hours between stimulation sessions), for a minimum of five days per week, for 28 days or ICU discharge, whichever comes first.
DEVICESham breath synchronized abdominal FESSham abdominal stimulation will be applied for 30 minutes twice per day (minimum of four hours between stimulation sessions), for a minimum of five days per week, for 28 days or ICU discharge, whichever comes first.

Timeline

Start date
2024-02-15
Primary completion
2025-12-31
Completion
2026-03-31
First posted
2023-03-08
Last updated
2025-11-12

Locations

27 sites across 4 countries: United States, Australia, France, Netherlands

Regulatory

Source: ClinicalTrials.gov record NCT05759013. Inclusion in this directory is not an endorsement.